Annual report pursuant to Section 13 and 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (DEFICIT)

v3.23.1
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (DEFICIT) - USD ($)
Common stock
Additional Paid-in Capital
Accumulated deficit
Total
Balance at beginning at Dec. 31, 2020   $ 37,139,000 $ (7,488,000) $ 29,651,000
Balance at beginning (in shares) at Dec. 31, 2020 13,830,351      
Changes in Stockholders' deficit        
Issuance of common stock for purchase of business   25,538,000   25,538,000
Issuance of common stock for purchase of business (in shares) 777,380      
Offering costs in connection with public offering   (2,471,000)   (2,471,000)
Issuance of common stock pursuant to exercise of stock options   80,000   $ 80,000
Issuance of common stock pursuant to exercise of stock options (in shares) 16,972     16,974
Stock-based compensation, net of forfeitures   4,843,000   $ 4,843,000
Stock-based compensation, net of forfeitures (in shares) 376,903      
Issuance of common stock in connection with public offering   35,000,000   35,000,000
Issuance of common stock in connection with public offering (in shares) 1,750,000      
Net loss     (12,491,000) (12,491,000)
Net loss       (12,491,000)
Balance at ending at Dec. 31, 2021   100,129,000 (19,979,000) 80,150,000
Balance at ending (in shares) at Dec. 31, 2021 16,751,606      
Changes in Stockholders' deficit        
Issuance of common stock for purchase of business   6,191,000   6,191,000
Issuance of common stock for purchase of business (in shares) 470,982      
Repurchase of common stock   (6,045,000)   (6,045,000)
Repurchase of common stock (in shares) (686,097)      
Stock-based compensation, net of forfeitures $ 932,071 9,351,000   9,351,000
Net loss     (27,626,000) (27,626,000)
Net loss       (27,626,000)
Balance at ending at Dec. 31, 2022   $ 109,626,000 $ (47,605,000) $ 62,021,000
Balance at ending (in shares) at Dec. 31, 2022 17,468,562